Stocktoria
Medline Inc. MDLN
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2025-12-17
Medline Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 |
|---|---|---|
| Gross margin | 26.4% | 27.3% |
| Operating margin | 7.8% | 8.4% |
| Net margin | 4.1% | — |
| FCF margin | 4.6% | 5.5% |
| Return on assets | 3.0% | — |
| Return on equity | 6.0% | — |
| Debt / equity | 0.65× | — |
| Current ratio | 4.29 | 3.39 |
| Revenue growth | 11.5% | — |
Source: SEC EDGAR filings · CIK 0002046386 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.